Cited by 287Neuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental DisordersCannabis and Cannabinoid Research

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling

Open access

Földy, Csaba, Malenka, Robert C., Südhof, Thomas C.·2013·Neuron

DOI 10.1016/j.neuron.2013.02.036PMC PMC3663050

Open this paper in CoChat — free account Open PDF

Abstract

Neuroligins are postsynaptic cell-adhesion molecules that interact with presynaptic neurexins. Rare mutations in neuroligins and neurexins predispose to autism, including a neuroligin-3 amino acid substitution (R451C) and a neuroligin-3 deletion. Previous analyses showed that neuroligin-3 R451C-knockin mice exhibit robust synaptic phenotypes but failed to uncover major changes in neuroligin-3 knockout mice, questioning the notion that a common synaptic mechanism mediates autism pathogenesis in patients with these mutations. Here, we used paired recordings in mice carrying these mutations to measure synaptic transmission at GABAergic synapses formed by hippocampal parvalbumin- and cholecystokinin-expressing basket cells onto pyramidal neurons. We demonstrate that in addition to unique gain-of-function effects produced by the neuroligin-3 R451C-knockin but not the neuroligin-3 knockout mutation, both mutations dramatically impaired tonic but not phasic endocannabinoid signaling. Our data thus suggest that neuroligin-3 is specifically required for tonic endocannabinoid signaling, raising the possibility that alterations in endocannabinoid signaling may contribute to autism pathophysiology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2013.02.036

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Epigenetic Regulations of GABAergic Neurotransmission: Relevance for Neurological Disorders and Epigenetic Therapy
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070
Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations
Klausberger, T., & Somogyi, P. (2008) · Science · doi:10.1126/science.1149381 · Cited by 2,050
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Neuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849
Self-citation
Role of Endogenous Cannabinoids in Synaptic Signaling
Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,616
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism
Sanders, S. J., Ercan-Sencicek, A. G., Hus, V., Luo, R., Murtha, M. T., Moreno-De-Luca, D., Chu, S. H., Moreau, M. P., Gupta, A. R., Thomson, S. A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.002 · Cited by 1,263
Neurexins Induce Differentiation of GABA and Glutamate Postsynaptic Specializations via Neuroligins
Graf, E. R., Zhang, X., Jin, S., Linhoff, M. W., & Craig, A. M. (2004) · Cell · doi:10.1016/j.cell.2004.11.035 · Cited by 1,029

Flagged first, then by citations

Show all 55 references

Sorted by citations

Items 101–200 of 287

Distortion of the normal function of synaptic cell adhesion molecules by genetic variants as a risk for autism spectrum disorders
Baig, D. N., Yanagawa, T., & Tabuchi, K. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.10.006 · Cited by 41
Paving the Way toward Personalized Medicine: Current Advances and Challenges in Multi-OMICS Approach in Autism Spectrum Disorder for Biomarkers Discovery and Patient Stratification
Mesleh, A. G., Abdulla, S. A., & El‐Agnaf, O. M. A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11010041 · Cited by 41
Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
Scarante, F. F., Ribeiro, M. A., Almeida-Santos, A. F., Guimarães, F. S., & Campos, A. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.618065 · Cited by 44
An Autism-Associated Neuroligin-3 Mutation Affects Developmental Synapse Elimination in the Cerebellum
Lai, S., Nakayama, H., Miyazaki, T., Nakazawa, T., Tabuchi, K., Hashimoto, K., Watanabe, M., & Kano, M. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.676891 · Cited by 42
Neurexins and their ligands at inhibitory synapses
Boxer, E. E., & Aoto, J. N. (2022) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2022.1087238 · Cited by 41
The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses
Hill, M. N., Haney, M., Hillard, C. J., Karhson, D. S., & Vecchiarelli, H. A. (2023) · Psychological Medicine · doi:10.1017/s0033291723002465 · Cited by 42
Axo‐glial communication through neurexin‐neuroligin signaling regulates myelination and oligodendrocyte differentiation
Proctor, D. T., Stotz, S. C., Scott, L. O. M., de la Hoz, C. L. R., Poon, K. W. C., Stys, P. K., & Colicos, M. A. (2015) · Glia · doi:10.1002/glia.22875 · Cited by 42
Wnt/β-catenin signaling stimulates the expression and synaptic clustering of the autism-associated Neuroligin 3 gene
Medina, M. A., Andrade, V., Caracci, M. O., Ávila, M. E., Verdugo, D. A., Vargas, M. F., Ugarte, G. D., Reyes, A. E., Opazo, C., & Ferrari, G. V. D. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0093-y · Cited by 40
Reduced inhibitory gate in the barrel cortex of Neuroligin3R451Cknock-in mice, an animal model of autism spectrum disorders
Cellot, G., & Cherubini, E. (2014) · Physiological Reports · doi:10.14814/phy2.12077 · Cited by 38
Synaptic basis of social dysfunction: a focus on postsynaptic proteins linking group‐ I m G lu R s with AMPAR s and NMDAR s
O’Connor, E. C., Bariselli, S., & Bellone, C. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12510 · Cited by 40
Autism Spectrum Disorders and Drug Addiction: Common Pathways, Common Molecules, Distinct Disorders?
Rothwell, P. E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00020 · Cited by 40
A pilot randomised placebo‐controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability
Efron, D., Freeman, J. L., Cranswick, N., Payne, J. M., Mulraney, M., Prakash, C., Lee, K. J., Taylor, K., & Williams, K. J. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14399 · Cited by 42
Perinatal Exposure to Bisphenol-A Impairs Spatial Memory through Upregulation of Neurexin1 and Neuroligin3 Expression in Male Mouse Brain
Kumar, D., & Thakur, M. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110482 · Cited by 37
Retracted
Neuroligin-3 confines AMPA receptors into nanoclusters, thereby controlling synaptic strength at the calyx of Held synapses
Han, Y., Cao, R., Qin, L., Chen, L. Y., Tang, A., Südhof, T. C., & Zhang, B. (2022) · Science Advances · doi:10.1126/sciadv.abo4173 · Cited by 38
Self-citation
Neuroligins Provide Molecular Links Between Syndromic and Nonsyndromic Autism
Singh, S. K., & Eroğlu, Ç. (2013) · Science Signaling · doi:10.1126/scisignal.2004102 · Cited by 38
UPR activation specifically modulates glutamate neurotransmission in the cerebellum of a mouse model of autism
Trobiani, L., Favaloro, F. L., Castro, M. A. D., Mattia, M. D., Cariello, M., Miranda, E., Canterini, S., Stefano, M. E. D., Comoletti, D., Limatola, C., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.026 · Cited by 36
Targeting oxytocin receptor (Oxtr)-expressing neurons in the lateral septum to restore social novelty in autism spectrum disorder mouse models
Horiai, M., Otsuka, A., Hidema, S., Hiraoka, Y., Hayashi, R., Miyazaki, S., Furuse, T., Mizukami, H., Teruyama, R., Tamura, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-79109-0 · Cited by 38
Specific Neuroligin3–αNeurexin1 signaling regulates GABAergic synaptic function in mouse hippocampus
Uchigashima, M., Konno, K., Demchak, E., Cheung, A., Watanabe, T., Keener, D. G., Abe, M., Le, T., Sakimura, K., Sasaoka, T., et al. (2020) · eLife · doi:10.7554/elife.59545 · Cited by 35
Neurexin-3 defines synapse- and sex-dependent diversity of GABAergic inhibition in ventral subiculum
Boxer, E. E., Seng, C., Lukacsovich, D., Kim, J., Schwartz, S. L., Kennedy, M. J., Földy, C., & Aoto, J. N. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110098 · Cited by 35
Self-citation
Possible therapeutic applications of cannabis in the neuropsychopharmacology field
Fernández‐Ruíz, J., Galve‐Roperh, I., Sagredo, O., & Guzmán, M. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.013 · Cited by 35
Neuregulin-1 Impairs the Long-term Depression of Hippocampal Inhibitory Synapses by Facilitating the Degradation of Endocannabinoid 2-AG
Du, H., Kwon, I., & Kim, J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5833-12.2013 · Cited by 33
Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
Calapai, G., Mannucci, C., Chinou, İ., Cardia, L., Calapai, F., Sorbara, E. E., Firenzuoli, B., Ricca, V., Gensini, G. F., & Firenzuoli, F. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2509129 · Cited by 36
Novel 3D Microscopic Analysis of Human Placental Villous Trees Reveals Unexpected Significance of Branching Angles
Haeussner, E., Buehlmeyer, A., Schmitz, C., von Koch, F. E., & Frank, H. (2014) · Scientific Reports · doi:10.1038/srep06192 · Cited by 32
Neuroligin3 splice isoforms shape inhibitory synaptic function in the mouse hippocampus
Uchigashima, M., Leung, M., Watanabe, T., Cheung, A., Le, T., Pallat, S., Dinis, A., Watanabe, M., Kawasawa, Y. I., & Futai, K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.012571 · Cited by 34
NMDA receptor hypofunction underlies deficits in parvalbumin interneurons and social behavior in neuroligin 3 R451C knockin mice
Cao, W., Li, J., Shen, L., Xia, Q.-Q., Du, Y.-L., Yang, Q., Ye, Y.-Z., Zeng, L., Li, X., Xu, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111771 · Cited by 31
Endocannabinoid Turnover
Fowler, C. J., Doherty, P., & Alexander, S. P. H. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.03.006 · Cited by 31
Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction
Melis, M., Greco, B., & Tonini, R. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12501 · Cited by 31
The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17
Zheng, Y., Verhoeff, T. A., Perez‐Pardo, P., Garssen, J., & Kraneveld, A. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010118 · Cited by 33
The utility of rodent models of autism spectrum disorders
Lázaro, M. T., & Golshani, P. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000183 · Cited by 36
GABAergic deficits and schizophrenia-like behaviors in a mouse model carrying patient-derived neuroligin-2 R215H mutation
Jiang, D., Wu, Z., Forsyth, C., Hu, Y., Yee, S., & Chen, G. (2018) · Molecular Brain · doi:10.1186/s13041-018-0375-6 · Cited by 31
Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date
Fung, L. K., & Hardan, A. Y. (2015) · CNS Drugs · doi:10.1007/s40263-015-0252-0 · Cited by 28
Mutations in neuroligin-3 in male mice impact behavioral flexibility but not relational memory in a touchscreen test of visual transitive inference
Norris, R. H. C., Churilov, L. P., Hannan, A. J., & Nithianantharajah, J. (2019) · Molecular Autism · doi:10.1186/s13229-019-0292-2 · Cited by 30
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms
Sirrs, S., van Karnebeek, C. D., Peng, X., Shyr, C., Tarailo-Graovac, M., Mandal, R., Testa, D., Dubin, D., Carbonetti, G., Glynn, S. E., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0248-3 · Cited by 28
Neuroligin-2 Determines Inhibitory Synaptic Transmission in the Lateral Septum to Optimize Stress-Induced Neuronal Activation and Avoidance Behavior
Troyano‐Rodriguez, E., Wirsig‐Wiechmann, C. R., & Ahmad, M. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.01.022 · Cited by 30
Role of the endocannabinoid system in neurological disorders
Zou, M., Li, D., Li, L., Wu, L., & Sun, C. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.03.002 · Cited by 27
Canabinoides ajudam a desvendar aspectos etiológicos em comum e trazem esperança para o tratamento de autismo e epilepsia
Malcher‐Lopes, R. (2014) · Revista da Biologia · doi:10.7594/revbio.13.01.07 · Cited by 29
Neuroligin-3 activates Akt-dependent Nrf2 cascade to protect osteoblasts from oxidative stress
Fan, J.-B., Yuan, K., Zhu, X., Cui, S., Yi, H., & Zhang, W. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.09.032 · Cited by 27
A novel computational biostatistics approach implies impaired dephosphorylation of growth factor receptors as associated with severity of autism
Wittkowski, K. M., Sonakya, V., Bigio, B., Tonn, M. K., Shic, F., Ascano, M., Nasca, C., & Simson, G. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.124 · Cited by 26
Understanding GABAergic synapse diversity and its implications for GABAergic pharmacotherapy
Krueger‐Burg, D. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2024.11.007 · Cited by 30
The Interplay between Synaptic Activity and Neuroligin Function in the CNS
Hu, X., Luo, J., & Xu, J. (2015) · BioMed Research International · doi:10.1155/2015/498957 · Cited by 27
Co-occurrence across time and space of drug- and cannabinoid- exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis
Reece, A. S., & Hulse, G. K. (2020) · BMC Public Health · doi:10.1186/s12889-020-09748-5 · Cited by 25
Copy number variants in neurexin genes: phenotypes and mechanisms
Fuccillo, M. V., & Pak, C. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.02.010 · Cited by 24
The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models
Pietropaolo, S., & Marsicano, G. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.031 · Cited by 23
Impaired synaptic plasticity in an animal model of autism exhibiting early hippocampal GABAergic-BDNF/TrkB signaling alterations
Sgritta, M., Vignoli, B., Pimpinella, D., Griguoli, M., Santi, S., Bialowas, A., Wiera, G., Zacchi, P., Malerba, F., Marchetti, C., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105728 · Cited by 24
Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders
Efron, D., & Taylor, K. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20085430 · Cited by 24
Aberrant mPFC GABAergic synaptic transmission and fear behavior in neuroligin-2 R215H knock-in mice
Chen, J., Dong, B., Feng, X., Jiang, D., Chen, G., Long, C., & Yang, L. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146671 · Cited by 23
The role of the endocannabinoid system in autism spectrum disorders: Evidence from mouse studies
Pietropaolo, S., Bellocchio, L., Bouzón‐Arnáiz, I., & Yee, B. K. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.016 · Cited by 24
Cellular and molecular mechanisms underlying autism spectrum disorders and associated comorbidities: A pathophysiological review
Dera, H. S. A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112688 · Cited by 26
Novel Interactive Partners of Neuroligin 3: New Aspects for Pathogenesis of Autism
Shen, C., Huo, L.-R., Zhao, X., Wang, P., & Zhong, N. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0470-9 · Cited by 23
Reduced susceptibility to induced seizures in the Neuroligin-3R451C mouse model of autism
Hill‐Yardin, E. L., Argyropoulos, A., Hosie, S., Rind, G. S., Anderson, P., Hannan, A. J., & O'Brien, T. J. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.024 · Cited by 21
The NG2 Protein Is Not Required for Glutamatergic Neuron–NG2 Cell Synaptic Signaling
Passlick, S., Trotter, J., Seifert, G., Steinhäuser, C., & Jabs, R. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu171 · Cited by 21
Paracetamol (Acetaminophen) and its Effect on the Developing Mouse Brain
Philippot, G., Hosseini, K., Yakub, A., Mhajar, Y., Hamid, M., Buratovic, S., & Fredriksson, R. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.867748 · Cited by 22
Combinatorial expression of neurexins and LAR-type phosphotyrosine phosphatase receptors instructs assembly of a cerebellar circuit
Sclip, A., & Südhof, T. C. (2023) · Nature Communications · doi:10.1038/s41467-023-40526-0 · Cited by 23
Self-citation
Mice with an autism‐associated R451C mutation in neuroligin‐3 show a cautious but accurate response style in touchscreen attention tasks
Burrows, E. L., May, C., Hill, T., Churliov, L., Johnson, K. A., & Hannan, A. J. (2021) · Genes Brain & Behavior · doi:10.1111/gbb.12757 · Cited by 20
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus
Xia, S., Zhou, Z., Leung, C., Zhu, Y., Pan, X., Qi, J., Morena, M., Hill, M. N., Xie, W., & Jia, Z. (2016) · eLife · doi:10.7554/elife.14653 · Cited by 21
Autism and associated disorders: cannabis as a potential therapy
Babayeva, M., Assefa, H., Basu, P., & Loewy, Z. G. (2022) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1401001 · Cited by 27
Social Isolation Alters Social and Mating Behavior in the R451C Neuroligin Mouse Model of Autism
Burrows, E. L., Eastwood, A. F., May, C., Kolbe, S., Hill, T., McLachlan, N. M., Churilov, L. P., & Hannan, A. J. (2017) · Neural Plasticity · doi:10.1155/2017/8361290 · Cited by 20
Neurexin1α Differentially Regulates Synaptic Efficacy within Striatal Circuits
Davatolhagh, M. F., & Fuccillo, M. V. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.108773 · Cited by 21
Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits
Montagner, P. S. S., Medeiros, W., da Silva, L. C. R., Borges, C. N., Brasil-Neto, J. P., Barbosa, V. D. D. S., Caixeta, F. V., & Malcher‐Lopes, R. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1210155 · Cited by 21
Differential Adulthood Onset mGlu5Signaling Saves Prefrontal Function in the Fragile X Mouse
Martin, H. G. S., Lassalle, O., & Manzoni, O. J. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw328 · Cited by 21
Presynaptic nanoscale components of retrograde synaptic signaling
Barti, B., Dudok, B., Kenesei, K., Zöldi, M., Miczán, V., Balla, G. Y., Zala, D., Tasso, M., Sagheddu, C., Kisfali, M., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado0077 · Cited by 19
Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL ‐α, induces autism spectrum disorder‐like and co‐morbid phenotypes in adult C57BL /J mice
Fyke, W., Alarcón, J. M., Velinov, M. T., & Chadman, K. K. (2021) · Autism Research · doi:10.1002/aur.2520 · Cited by 19
Current Approaches to the Pharmacologic Treatment of Core Symptoms Across the Lifespan of Autism Spectrum Disorder
Pandina, G., Ring, R. H., Bangerter, A., & Ness, S. L. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.08.003 · Cited by 19
Tonic Endocannabinoid Signaling Gates Synaptic Plasticity in Dorsal Raphe Nucleus Serotonin Neurons Through Peroxisome Proliferator-Activated Receptors
Oubraim, S., Wang, R., Hausknecht, K. A., Shen, R., & Haj‐Dahmane, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.691219 · Cited by 18
Deep Survey of GABAergic Interneurons: Emerging Insights From Gene-Isoform Transcriptomics
Que, L., Winterer, J., & Földy, C. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00115 · Cited by 15
Self-citation
Genome-wide effects of social status on DNA methylation in the brain of a cichlid fish, Astatotilapia burtoni
Hilliard, A. T., Xie, D., Ma, Z., Snyder, M. P., & Fernald, R. D. (2019) · BMC Genomics · doi:10.1186/s12864-019-6047-9 · Cited by 19
Autism-associated synaptic mutations impact the gut-brain axis in mice
Lee, C. Y. Q., Franks, A. E., & Hill‐Yardin, E. L. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.072 · Cited by 18
Noncanonical Activity of Endocannabinoids and Their Receptors in Central and Peripheral Synapses
Balezina, O. P., Tarasova, E. O., & Gaydukov, A. E. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921070038 · Cited by 18
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder
Schultz, S. T., & Gould, G. G. (2016) · Autism - Open Access · doi:10.4172/2165-7890.1000170 · Cited by 17
Does cannabidiol reduce severe behavioural problems in children with intellectual disability? Study protocol for a pilot single-site phase I/II randomised placebo controlled trial
Efron, D., Taylor, K., Payne, J. M., Freeman, J. L., Cranswick, N., Mulraney, M., Prakash, C., Lee, K. J., & Williams, K. J. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034362 · Cited by 18
Altered global modular organization of intrinsic functional connectivity in autism arises from atypical node‐level processing
Sigar, P., Uddin, L. Q., & Roy, D. (2022) · Autism Research · doi:10.1002/aur.2840 · Cited by 17
Current Approaches to the Pharmacologic Treatment of Core Symptoms Across the Lifespan of Autism Spectrum Disorder
Pandina, G., Ring, R. H., Bangerter, A., & Ness, S. L. (2020) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2019.12.004 · Cited by 16
Potential of cannabinoids as treatments for autism spectrum disorders
Nezgovorova, V., Ferretti, C. J., Taylor, B. P., Shanahan, E. C., Uzunova, G., Hong, K., Devinsky, O., & Hollander, E. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.048 · Cited by 16
The Emerging Role of the Gut–Brain–Microbiota Axis in Neurodevelopmental Disorders
Hosie, S., Abo-Shaban, T., Lee, C. Y. Q., Matta, S. M., Shindler, A. E., Gore, R., Sharna, S. S., Herath, M., Crack, P. J., Franks, A. E., et al. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-05843-1_14 · Cited by 16
Prenatal THC exposure drives sex-specific alterations in spatial memory and hippocampal excitatory/inhibitory balance in adolescent rats
Castelli, V., Lavanco, G., Tringali, G., D’Amico, C., Feo, S., Bartolomeo, M. D., D’Addario, C., Kuchař, M., Brancato, A., & Cannizzaro, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117699 · Cited by 15
Cytokine-dependent bidirectional connection between impaired social behavior and susceptibility to seizures associated with maternal immune activation in mice
Washington, J., Kumar, U., Medel‐Matus, J., Shin, D. H., Sankar, R., & Mazarati, A. M. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.05.040 · Cited by 14
Evidence for a Common Endocannabinoid-Related Pathomechanism in Autism Spectrum Disorders
Krueger‐Burg, D., & Brose, N. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.030 · Cited by 14
Endocannabinoid Mediates Excitatory Synaptic Function of β-Neurexins. Commentary: β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling
Wang, H. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00203 · Cited by 14
Abnormal Astrocytosis in the Basal Ganglia Pathway of Git1−/− Mice
Lim, S., & Mah, W. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0041 · Cited by 12
Integrating endocannabinoid signaling, CCK interneurons, and hippocampal circuit dynamics in behaving animals
Malhotra, S., Donneger, F., Farrell, J. S., Dudok, B., Losonczy, A., & Soltész, I. (2025) · Neuron · doi:10.1016/j.neuron.2025.03.016 · Cited by 14
Neuroligins Differentially Mediate Subtype-Specific Synapse Formation in Pyramidal Neurons and Interneurons
Xia, Q.-Q., Xu, J., Liao, T., Yu, J., Shi, L., Xia, J., Luo, J.-H., & Xu, J. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00347-y · Cited by 12
A blueprint for research on Shankopathies: A view from research on autism spectrum disorder
Carbonetto, S. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22150 · Cited by 13
Molecular Mechanisms of Synaptic Specificity: Spotlight on Hippocampal and Cerebellar Synapse Organizers.
Park, D., Bae, S., Yoon, T. H., & Ko, J. (2018) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2018.0081 · Cited by 10
Autism-associated neuroligin 3 deficiency in medial septum causes social deficits and sleep loss in mice
Sun, H., Shen, Y., Ni, P., Liu, X., Li, Y., Qiu, Z., Su, J., Wang, Y., Wu, M., Kong, X., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176770 · Cited by 16
Patterns of Cannabis- and Substance-Related Congenital General Anomalies in Europe: A Geospatiotemporal and Causal Inferential Study
Reece, A. S., & Hulse, G. K. (2023) · Pediatric Reports · doi:10.3390/pediatric15010009 · Cited by 11
Medical cannabis for paediatric developmental–behavioural and psychiatric disorders
Efron, D., & Freeman, J. L. (2018) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.13902 · Cited by 12
Neuroligin-3 protects retinal cells from H2O2-induced cell death via activation of Nrf2 signaling
Li, X., Huang, D. F., Yu, Q., Yang, J., & Yao, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.141 · Cited by 11
The complex genetics in autism spectrum disorders
Hua, R., Wei, M., & Zhang, C. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4893-5 · Cited by 11
Neuron-secreted NLGN3 ameliorates ischemic brain injury via activating Gαi1/3-Akt signaling
Chen, Z., Shi, X., Zhang, X., Yang, F., Li, K., Fang, Q., Cao, C., Chen, X.-H., & Peng, Y. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06219-8 · Cited by 12
Syncytial nuclei accumulate at the villous surface in IUGR while proliferation is unchanged
Haeussner, E., Schmitz, C., Grynspan, D., von Koch, F. E., & Frank, H. (2017) · Placenta · doi:10.1016/j.placenta.2017.10.004 · Cited by 9
Imbalance of flight–freeze responses and their cellular correlates in the Nlgn3−/y rat model of autism
Anstey, N. J., Kapgal, V., Tiwari, S., Watson, T. C., Toft, A. K. H., Dando, O., Inkpen, F. H., Baxter, P. S., Kozić, Z., Jackson, A. D., et al. (2022) · Molecular Autism · doi:10.1186/s13229-022-00511-8 · Cited by 13
Cannabinoids as Regulators of Neural Development and Adult Neurogenesis
Campos, A. C., Paraíso‐Luna, J., Fogaça, M. V., Guimarães, F. S., & Galve‐Roperh, I. (2017) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-49343-5_6 · Cited by 10
Loss of Neuroligin3 specifically downregulates retinal GABAAα2 receptors without abolishing direction selectivity
Hoon, M., Krishnamoorthy, V., Gollisch, T., Falkenburger, B. H., & Varoqueaux, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181011 · Cited by 10
Synapses as Therapeutic Targets for Autism Spectrum Disorders: An International Symposium Held in Pavia on July 4th, 2014
Curatolo, P., Ben‐Ari, Y., Bozzi, Y., Catania, M. V., Dâ€TMAngelo, E., Mapelli, L., Oberman, L. M., Rosenmund, C., & Cherubini, E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00309 · Cited by 11
Electrophysiological Measurement of Cannabinoid‐Mediated Synaptic Modulation in Acute Mouse Brain Slices
Báldi, R., Ghosh, D., Grueter, B. A., & Patel, S. (2016) · Current Protocols in Neuroscience · doi:10.1002/cpns.8 · Cited by 10
The Endocannabinoid System in Prefrontal Synaptopathies
Scheyer, A. F., Martin, H. G. S., & Manzoni, O. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_7 · Cited by 10
PAK1 regulates inhibitory synaptic function via a novel mechanism mediated by endocannabinoids
Xia, S., Zhou, Z., & Jia, Z. (2016) · Small GTPases · doi:10.1080/21541248.2016.1228793 · Cited by 10
Nrf2 signaling pathway: focus on oxidative stress in osteoporosis
Gu, H.-Y., Liu, N., Lin, F.-X., & Yin, J. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07592-0 · Cited by 10
European Epidemiological Patterns of Cannabis- and Substance-Related Congenital Neurological Anomalies: Geospatiotemporal and Causal Inferential Study
Reece, A. S., & Hulse, G. K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010441 · Cited by 9
Region-Specific Phosphorylation Determines Neuroligin-3 Localization to Excitatory Versus Inhibitory Synapses
Altas, B., Tuffy, L. P., Patrizi, A., Dimova, K. P., Soykan, T., Brandenburg, C., Romanowski, A. J., Whitten, J., Robertson, C. D., Khim, S. N., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.12.020 · Cited by 11

Authors: Földy, C., Malenka, R. C., & Südhof, T. C.
Affiliations: Stanford Medicine (US)
Howard Hughes Medical Institute (US)
Corresponding author: Földy, Csaba
Südhof, Thomas C.
ORCID: Földy, Csaba
Malenka, Robert C.
Südhof, Thomas C.
Venue: Neuron
Publisher: Elsevier BV
Published: 2013-05
Volume: 78
Issue: 3
Pages: 498-509
ISSN: 0896-6273 (ISSN-L)
DOI: 10.1016/j.neuron.2013.02.036
PMC: PMC3663050
OpenAlex: W2142679888
Cited by: 287
References: 55
Citations by year: 2026: 7 · 2025: 16 · 2024: 12 · 2023: 21 · 2022: 25 · 2021: 23 · 2020: 30 · 2019: 19 · 2018: 20 · 2017: 27 · 2016: 24 · 2015: 32 · 2014: 23 · 2013: 8
FWCI: 14.07
Type: journal article
Language: en
Update notices: erratum (2013-07-10)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 372 d)
Locations: Neuron (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Howard Hughes Medical Institute
Simons Foundation
National Institute of Mental Health (P50MH086403)
National Institute on Drug Abuse (R01DA030379, K99DA034029)
National Institute of Neurological Disorders and Stroke (NS069375, P30NS069375)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Keywords: neuroligin-3, autism spectrum disorder, GABAergic synapses, basket cells, parvalbumin, cholecystokinin, synaptic transmission, gain-of-function, neurexin, autism pathogenesis
MeSH terms: Animals, Cells, Cultured, Cholecystokinin, Hippocampus, Membrane Proteins, Mice, Transgenic, Mutation, Nerve Tissue Proteins, Synaptic Transmission, Neurons, Parvalbumins, Synapses, Signal Transduction, Cell Adhesion Molecules, Neuronal, Mice, Gene Knock-In Techniques, GABAergic Neurons, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks